| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,845.20
|
|
Change (%)
|
-45.95 (-2.43%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,832.65
-
1,909.85
|
|
52-Week Range (RS)
|
1,547.25
-
1,917.15
|
|
Beta (1 Year)
|
0.51
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Board of Sun Pharmaceuticals Industries recommends final dividend |
| Sun Pharmaceutical Industries consolidated net profit rises 26.24% in the March 2026 quarter |
| Sun Pharma Q4 PAT jumps 26% YoY to Rs 2,714 cr |
| Sun Pharmaceuticals Industries to declare Quarterly Results |
| Sun Pharmaceutical receives credit ratings from CRISIL and ICRA |
| Sun Pharmaceutical Industries Ltd spurts 0.33%, gains for fifth straight session |
| Sun Pharma surges post deal to acquire US-based pharmaceutical company Organon for $3.99 billion |
| Sun Pharmaceuticals enters definitive agreement to acquire Organon |
| Sun Pharma incorporates subsidiary in U.S. |
| Kesoram Industries Ltd leads losers in 'A' group |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
15-May-2026 |
1880.00 |
-1.85 |
| 1Month |
22-Apr-2026 |
1669.20 |
10.54 |
| 3Month |
23-Feb-2026 |
1732.20 |
6.52 |
| 6Month |
24-Nov-2025 |
1781.20 |
3.59 |
| 1Year |
22-May-2025 |
1720.00 |
7.28 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.74 |
3621.36 |
| ICICI Pru Value Fund |
4.70 |
2797.93 |
| SBI BSE SENSEX ETF |
2.14 |
2532.78 |
| ICICI Pru Equity & Debt Fund |
4.33 |
2181.54 |
| ICICI Pru Large Cap Fund |
2.69 |
2034.33 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,398.95 |
-0.19 |
1,672.20 |
1,165.55 |
113,007.26 |
| Dr Reddys Laboratories Ltd |
1,307.10 |
-0.85 |
1,377.95 |
1,149.00 |
109,098.01 |
| Zydus Lifesciences Ltd |
1,038.95 |
0.27 |
1,093.95 |
835.85 |
104,542.68 |
| Lupin Ltd |
2,279.50 |
-0.26 |
2,492.00 |
1,838.65 |
104,222.36 |
| Mankind Pharma Ltd |
2,480.50 |
-1.37 |
2,726.75 |
1,909.90 |
102,422.13 |
|
|
|
|